Spinal Tech

The Asia-Pacific spine surgery devices market is expected to hit $2.98 billion by 2022, a Zion Research report found, according to EconoTimes.

The North American Spine Society issued the first coverage recommendations for electrical bone growth stimulators.

Spine Wave plans to implement a full launch of its Velocity P Expandable Interbody Device in mid-November.

Vertera Spine reported positive early outcomes for the COHERE Cervical Interbody Fusion Device.

Here are eight devices that were recently launched or released.

About a decade ago, a novel technology called the Neuro-Spinal Scaffold for patients with spinal cord injury came to fruition. Today, Cambridge, Mass.-based InVivo Therapeutics' INSPIRE study is underway to prove the technology's efficacy.

The FDA cleared Lyon, France-based Medicrea's PASS XS posterior fixation and LigaPASS XS band connector components.

Brad Prybis, MD, of Carrollton (Ga.) Orthopaedic Clinic, performed the first anterior cervical fusion using Meditech's CURE Anterior Cervical Plate.

Thomas B. Scully, MD, of Northwest NeuroSpecialists in Tucson, Ariz., became the first surgeon to implant Life Spine's PRO-LINK Ti Stand-Alone Cervical Spacer System.

Earlier this week, Pfizer said it will sell a biosimilar version of Johnson & Johnson's Remicade, a rheumatoid arthritis treatment, causing investors to worry about the competition's impact on Johnson & Johnson's sales, according to STAT.